Irene Aldecoa
About Irene Aldecoa
Irene Aldecoa is the Executive Director and WW CAR T Commercial Operations Lead at Bristol Myers Squibb in Basel, Switzerland, with extensive experience in strategic planning and commercial strategy within the pharmaceutical industry.
Executive Director at Bristol Myers Squibb
Irene Aldecoa holds the position of Executive Director and WW CAR T Commercial Operations Lead at Bristol Myers Squibb. Based in Basel, Switzerland, she spearheads the global commercial operations for CAR T cell therapy, aligning with the company's strategic goals in delivering innovative treatment solutions.
Professional Experience at Novartis
From 2012 to 2020, Irene Aldecoa held various significant roles at Novartis and Novartis Oncology. She started as Strategic Planning Head and progressed to key positions such as Commercial Operations & Strategic Planning Head, Marketing Director for Immunology & Dermatology US, and Director for Cell & Gene Therapy HS Onboarding Head Europe (CAR-T). These roles were based in both the Basel Area of Switzerland and the United States.
Career at Deloitte and Accenture
Irene Aldecoa spent five years at Deloitte as Manager Strategy & Operations and three years as Consultant and Analyst at Accenture España. Her tenure at these firms provided her with a strong foundation in strategic planning, operations management, and consulting.
Education and Qualifications
Irene Aldecoa earned her Master of Engineering (MEng) in Telecommunications Engineering from the Universitat Politècnica de Catalunya, where she studied from 1997 to 2003. She also completed her Bac. S from Lycée Français de Barcelone from 1988 to 1997, building a strong academic foundation that supports her professional expertise.
Expertise in Pharmaceutical Industry
Specializing in strategic planning and commercial strategy, Irene Aldecoa has extensive experience and expertise in M&A/Post Merger Integration within the pharmaceutical industry. Her role at Bristol Myers Squibb and previous positions at Novartis have cemented her proficiency in operations management and commercial strategies.